FdaApplication
NDA 214621
Identifiers
- fda_app_no: NDA214621
Properties
| Property | Value |
|---|---|
| applicant_name | SUMITOMO PHARMA AMERICA INC |
| application_type | NDA |
| approval_date | 2020-12-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORGOVYX | RELUGOLIX | 120MG | TABLET;ORAL |
1 product